{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:21:11Z","timestamp":1784042471596,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,10]]},"DOI":"10.7759\/cureus.43253","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T07:12:16Z","timestamp":1691651536000},"source":"Crossref","is-referenced-by-count":8,"title":["The Efficacy of Carvedilol in Comparison to Propranolol in Reducing the Hepatic Venous Pressure Gradient and Decreasing the Risk of Variceal Bleeding in Adult Cirrhotic Patients: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Lana","family":"Dardari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purva","family":"Dahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Toriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Satnarine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zareen","family":"Zohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ademiniyi","family":"Adelekun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi D","family":"Seffah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korlos","family":"Salib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana  P","family":"Arcia Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim WR","year":"2002","unstructured":"Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002, 36:227-42. 10.1053\/jhep.2002.34734","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018, 69:406-60. 10.1016\/j.jhep.2018.03.024","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman SL","year":"2010","unstructured":"Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010, 7:425-36. 10.1038\/nrgastro.2010.97","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao G","year":"2010","unstructured":"Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010, 51:1445-9. 10.1002\/hep.23478","journal-title":"Hepatology"},{"key":"ref5","unstructured":"Treatment of chronic hepatitis C infection overview. (2023). Accessed. 04\/06\/2023: https:\/\/www.hepatitisc.uw.edu\/go\/treatment-infection."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.1.6","article-title":"Hepatic venous pressure gradient: clinical use in chronic liver disease","volume":"20","author":"Suk KT","year":"2014","unstructured":"Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014, 20:6-14. 10.3350\/cmh.2014.20.1.6","journal-title":"Clin Mol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i20.6117","article-title":"Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis","volume":"21","author":"Garbuzenko DV","year":"2015","unstructured":"Garbuzenko DV. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J Gastroenterol. 2015, 21:6117-26. 10.3748\/wjg.v21.i20.6117","journal-title":"World J Gastroenterol"},{"key":"ref8","article-title":"Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis [Article in Russian]","volume":"86","author":"Garbuzenko DV","year":"2014","unstructured":"Garbuzenko DV. Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis [Article in Russian]. Ter Arkh. 2014, 86:90-5.","journal-title":"Ter Arkh"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15690\/vramn.v68i1.538","article-title":"The mechanisms of adaptation of the vascular bed to hemodynamic changes in portal hypertension [Article in Russian]","author":"Garbuzenko DV","year":"2013","unstructured":"Garbuzenko DV. The mechanisms of adaptation of the vascular bed to hemodynamic changes in portal hypertension [Article in Russian]. Vestn Ross Akad Med Nauk. 2013, 52-7. 10.15690\/vramn.v68i1.538","journal-title":"Vestn Ross Akad Med Nauk"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2426644\/v1","article-title":"Carvedilol as primary and secondary prophylaxis to prevent variceal hemorrhage in patients with hepatic cirrhosis: a systematic review and meta-analysis","author":"Mariadi K","year":"2023","unstructured":"Mariadi K, Daniella D, Paulus IB, Somayana G, Sindhughosa DA. Carvedilol as primary and secondary prophylaxis to prevent variceal hemorrhage in patients with hepatic cirrhosis: a systematic review and meta-analysis. Res Sq . 2023, 1-15. 10.21203\/rs.3.rs-2426644\/v1","journal-title":"Res Sq"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002907.pub2","article-title":"Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding","volume":"2010","author":"Chavez-Tapia NC","year":"2010","unstructured":"Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010, 2010:CD002907. 10.1002\/14651858.CD002907.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/01.mog.0000218962.93806.9a","article-title":"Portal hypertension","volume":"22","author":"Garcia-Tsao G","year":"2006","unstructured":"Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2006, 22:254-62. 10.1097\/01.mog.0000218962.93806.9a","journal-title":"Curr Opin Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"de Franchis R","year":"2005","unstructured":"de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005, 43:167-76. 10.1016\/j.jhep.2005.05.009","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann RJ","year":"2004","unstructured":"Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004, 39:280-2. 10.1002\/hep.20062","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll C","year":"2007","unstructured":"Ripoll C, Groszmann R, Garcia-Tsao G, et al.. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. J. Gastroenterol . 2007, 133:481-488. 10.1053\/j.gastro.2007.05.024","journal-title":"J. Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis R","year":"2010","unstructured":"de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010, 53:762-8. 10.1016\/j.jhep.2010.06.004","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.016","article-title":"Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study","volume":"126","author":"Bureau C","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P, et al.. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004, 126:469-75. 10.1053\/j.gastro.2003.11.016","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v13.i7.731","article-title":"Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis","volume":"13","author":"Pfisterer N","year":"2021","unstructured":"Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis. World J Hepatol. 2021, 13:731-46. 10.4254\/wjh.v13.i7.731","journal-title":"World J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cld.92","article-title":"Primary prophylaxis of esophageal variceal bleeding","volume":"1","author":"Simonetto DA","year":"2012","unstructured":"Simonetto DA, Shah VH. Primary prophylaxis of esophageal variceal bleeding. Clin Liver Dis (Hoboken). 2012, 1:147-50. 10.1002\/cld.92","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao G","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017, 65:310-35. 10.1002\/hep.28906","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.07.012","article-title":"Varices and variceal hemorrhage in cirrhosis: a new view of an old problem","volume":"13","author":"Garcia-Tsao G","year":"2015","unstructured":"Garcia-Tsao G, Bosch J. Varices and variceal hemorrhage in cirrhosis: a new view of an old problem. Clin Gastroenterol Hepatol. 2015, 13:2109-17. 10.1016\/j.cgh.2015.07.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12360","article-title":"Beta-blockers in portal hypertension: new developments and controversies","volume":"34","author":"Tripathi D","year":"2014","unstructured":"Tripathi D, Hayes PC. Beta-blockers in portal hypertension: new developments and controversies. Liver Int. 2014, 34:655-67. 10.1111\/liv.12360","journal-title":"Liver Int"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger T","year":"2013","unstructured":"Reiberger T, Ulbrich G, Ferlitsch A, et al.. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 2013, 62:1634-41. 10.1136\/gutjnl-2012-304038","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.58767","article-title":"Noninvasive prediction of large esophageal varices in chronic liver disease patients","volume":"16","author":"Sarangapani A","year":"2010","unstructured":"Sarangapani A, Shanmugam C, Kalyanasundaram M, Rangachari B, Thangavelu P, Subbarayan JK. Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol. 2010, 16:38-42. 10.4103\/1319-3767.58767","journal-title":"Saudi J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref26","unstructured":"RoB 2. a revised Cochrane risk-of-bias tool for randomized trials. (2023). Accessed: 04\/08\/2023: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-011-0142-4","article-title":"Evaluation of treatment with carvedilol in comparison to propranolol in primary\/secondary prophylaxis of gastroesophageal variceal bleeding","volume":"30","author":"Agarwala V","year":"2011","unstructured":"Agarwala V, Prakash G, Singh R, et al.. Evaluation of treatment with carvedilol in comparison to propranolol in primary\/secondary prophylaxis of gastroesophageal variceal bleeding. Indian J Gastroenterol. 2011, 30:1-105. 10.1007\/s12664-011-0142-4","journal-title":"Indian J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis","volume":"30","author":"Ba\u00f1ares R","year":"1999","unstructured":"Ba\u00f1ares R, Moitinho E, Piqueras B, Casado M, Garc\u00eda-Pag\u00e1n JC, de Diego A, Bosch J. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology. 1999, 30:79-83. 10.1002\/hep.510300124","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36947","article-title":"Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis","volume":"36","author":"Ba\u00f1ares R","year":"2002","unstructured":"Ba\u00f1ares R, Moitinho E, Matilla A, et al.. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology. 2002, 36:1367-73. 10.1053\/jhep.2002.36947","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2002.02674.x","article-title":"Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics","volume":"17","author":"De BK","year":"2002","unstructured":"De BK, Das D, Sen S, Biswas PK, Mandal SK, Majumdar D, Maity AK. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics. J Gastroenterol Hepatol. 2002, 17:183-9. 10.1046\/j.1440-1746.2002.02674.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9765-y","article-title":"Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1\u00a0month in patients with index variceal bleed: RCT","volume":"11","author":"Gupta V","year":"2017","unstructured":"Gupta V, Rawat R, Shalimar, Saraya A. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1\u00a0month in patients with index variceal bleed: RCT. Hepatol Int. 2017, 11:181-7. 10.1007\/s12072-016-9765-y","journal-title":"Hepatol Int"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2020.08.009","article-title":"Long-term outcomes with carvedilol versus propranolol in patients with index variceal bleed: 6-year follow-up study","volume":"11","author":"Sharma S","year":"2021","unstructured":"Sharma S, Agarwal S, Gunjan D, et al.. Long-term outcomes with carvedilol versus propranolol in patients with index variceal bleed: 6-year follow-up study. J Clin Exp Hepatol. 2021, 11:343-53. 10.1016\/j.jceh.2020.08.009","journal-title":"J Clin Exp Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2012.666673","article-title":"Carvedilol or propranolol in portal hypertension? A randomized comparison","volume":"47","author":"Hobolth L","year":"2012","unstructured":"Hobolth L, M\u00f8ller S, Gr\u00f8nb\u00e6k H, Roelsgaard K, Bendtsen F, Feldager Hansen E. Carvedilol or propranolol in portal hypertension? A randomized comparison. Scand J Gastroenterol. 2012, 47:467-74. 10.3109\/00365521.2012.666673","journal-title":"Scand J Gastroenterol"},{"key":"ref34","article-title":"Systolic Hypertension","author":"Tan JL","year":"2023","unstructured":"Tan JL, Thakur K. Systolic Hypertension. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/BF01468983","article-title":"Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl) [Article in German]","volume":"53","author":"Stumpe KO","year":"1975","unstructured":"Stumpe KO, Vetter H, Hessenbruch V, D\u00fcsing R, Kolloch R, Kr\u00fcck F. Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl) [Article in German]. Klin Wochenschr. 1975, 53:907-11. 10.1007\/BF01468983","journal-title":"Klin Wochenschr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan R","year":"2014","unstructured":"Jalan R, Saliba F, Pavesi M, et al.. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014, 61:1038-47. 10.1016\/j.jhep.2014.06.012","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23045","article-title":"Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed","volume":"50","author":"Tripathi D","year":"2009","unstructured":"Tripathi D, Ferguson JW, Kochar N, et al.. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology. 2009, 50:825-33. 10.1002\/hep.23045","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han G","year":"2011","unstructured":"Han G, Qi X, He C, et al.. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011, 54:78-88. 10.1016\/j.jhep.2010.06.029","journal-title":"J Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao G","year":"2008","unstructured":"Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology. 2008, 48:2064-77. 10.1002\/hep.22605","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1564794","article-title":"Hepatorenal syndrome: a review of pathophysiology and current treatment options","volume":"32","author":"Erly B","year":"2015","unstructured":"Erly B, Carey WD, Kapoor B, McKinney JM, Tam M, Wang W. Hepatorenal syndrome: a review of pathophysiology and current treatment options. Semin Intervent Radiol. 2015, 32:445-54. 10.1055\/s-0035-1564794","journal-title":"Semin Intervent Radiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim WR","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, et al.. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008, 359:1018-26. 10.1056\/NEJMoa0801209","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14607","article-title":"Editorial: optimal dose of carvedilol in portal hypertension\u2026nearly there","volume":"47","author":"Tripathi D","year":"2018","unstructured":"Tripathi D, Stanley AJ. Editorial: optimal dose of carvedilol in portal hypertension\u2026nearly there. Aliment Pharmacol Ther. 2018, 47:1328-9. 10.1111\/apt.14607","journal-title":"Aliment Pharmacol Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra E","year":"2014","unstructured":"Sinagra E, Perricone G, D'Amico M, Tin\u00e8 F, D'Amico G. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther. 2014, 39:557-68. 10.1111\/apt.12634","journal-title":"Aliment Pharmacol Ther"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(98)70372-5","article-title":"Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension","volume":"115","author":"Albillos A","year":"1998","unstructured":"Albillos A, Garc\u00eda-Pag\u00e1n JC, Iborra J, et al.. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Gastroenterology. 1998, 115:116-23. 10.1016\/s0016-5085(98)70372-5","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159068-the-efficacy-of-carvedilol-in-comparison-to-propranolol-in-reducing-the-hepatic-venous-pressure-gradient-and-decreasing-the-risk-of-variceal-bleeding-in-adult-cirrhotic-patients-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:39Z","timestamp":1707508779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159068-the-efficacy-of-carvedilol-in-comparison-to-propranolol-in-reducing-the-hepatic-venous-pressure-gradient-and-decreasing-the-risk-of-variceal-bleeding-in-adult-cirrhotic-patients-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.43253","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}